1. Comparison of four chemotherapy regimens for advanced non–small-cell lung cancer;Schiller;N Engl J Med,2002
2. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non–small-cell lung cancer;Scagliotti;J Clin Oncol,2008
3. FLEX: a randomized, multicenter, phase III study of cetuximab in combination with cisplatin/vinorelbine (CV) versus CV alone in the first-line treatment of patients with advanced non–small-cell lung cancer (NSCLC) (abstract 3);Pirker;J Clin Oncol,2008
4. Cetuximab plus chemotherapy in patients with advanced non–small-cell lung cancer (FLEX): an open-label randomised phase III trial;Pirker;Lancet,2009
5. Panitumumab, a fully human antibody, combined with paclitaxel and carboplatin versus paclitaxel and carboplatin alone for first line advanced non–small-cell lung cancer: a preliminary analysis;Crawford;Proc European Cancer Congress,2005